AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
April 12th, 2021
Announcements
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 5th, 2021
Announcements
AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
March 30th, 2021
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
March 15th, 2021
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference
March 9th, 2021
Announcements
Using AI to Predict Clinical Trial Success
February 10th, 2021
Announcements
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
February 1st, 2021
Announcements
AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results
January 7th, 2021
Announcements
AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
January 4th, 2021
Announcements
